These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 4594383

  • 1. [Treatment of Parkinson's syndrome using L-dopa. 2].
    Glabb J, Hübner W, Glabb S.
    Z Arztl Fortbild (Jena); 1973 Aug 01; 67(15):745-53. PubMed ID: 4594383
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Combination of L-dopa and sulpiride in the treatment of Parkinson's disease].
    Brion S, Guérin R.
    Cah Med; 1973 Jul 01; 14(8):695-8. PubMed ID: 4602472
    [No Abstract] [Full Text] [Related]

  • 4. [Experiences with L-DOPA (Eldopal) treatment of 40 patients with Parkinson's disease].
    Postma JU, Stam FC, Meerlo HJ.
    Ned Tijdschr Geneeskd; 1971 Apr 17; 115(16):701-7. PubMed ID: 5551426
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L, Vecchi L.
    Clin Ter; 1970 May 15; 53(3):259-69. PubMed ID: 4917328
    [No Abstract] [Full Text] [Related]

  • 6. [L-dopa effect in Parkinson's syndrome].
    Römer F, Bettag W, Bock WJ.
    Z Allgemeinmed; 1971 Feb 28; 47(6):281-3. PubMed ID: 5571715
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases)].
    Mazza C, Buffatti PF, Bazzan A, Lion P.
    Fracastoro; 1970 Feb 28; 63(5):768-73. PubMed ID: 5519378
    [No Abstract] [Full Text] [Related]

  • 11. [Treatment of the parkinsonian syndrome with L-dopa and amantadine].
    Pendefunda GH, Pollingher B, Stefanache F, Gavril A, Oprişan C, Merling M, Nemţeanu E, Ciuntu M, Koropitzer I.
    Neurol Psihiatr Neurochir; 1973 Feb 28; 18(6):559-68. PubMed ID: 4790488
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of Parkinson's disease with L-dopa. 77 cases].
    Boudin G, Castaigne P, Lhermitte F, Beck H, Guillard A, Marteau R, Pepin B, Rondot P, Raphy B.
    Rev Neurol (Paris); 1970 Feb 28; 122(2):89-102. PubMed ID: 4931719
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor].
    Guillard A.
    Brux Med; 1972 Oct 28; 52(10):673-80. PubMed ID: 4656191
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.